Mark W. Womack, who has successfully led BioCina's explosive growth and development over the last two years, will continue as ...
I arrived from South Florida to a welcoming Boulder community, greeted by sky-reaching mountains and the unmistakable chill ...
She added that the biopharma sector is a progressive one that recognises skills, rather than just academic qualifications. “There will be more students who are more willing to start work ...
Looking for a biopharma job? Check out the BioSpace list of 12 top companies hiring life sciences professionals like you. There were 8% fewer job postings live on the BioSpace website in December than ...
In the race to bolster pipelines and drive growth, biopharma manufacturers are reexamining traditional practices and reimagining market research protocols. Biopharma business development and licensing ...
REPUBLIC COUNTY – The Kansas Bureau of Investigation (KBI) has secured the arrest of a man connected to the death of a Belleville infant. On Thursday, Jan. 2 at approximately 11 a.m., William ...
Drugmakers are expected to increase list prices on more than 1,000 medicines this year, and already raised the prices on about 250 drugs on Jan … ...
Novo aims to show semaglutide can help slow the cognitive decline associated with the condition. A company spokesperson told BioPharma Dive results should be available sometime in 2025. Analysts from ...
UK-based pharmaceutical giant AstraZeneca has announced plans to restructure its biopharma unit to concentrate on next-generation therapeutics. “In the Biopharmaceutical Business Unit, we are now ...
India's biopharma sector achieved significant milestones in 2024, reinforcing its position as a global leader in affordable healthcare solutions. The industry's focus on biologics, vaccines, medical ...
The Barton County Sheriff's Office requested the KBI investigate at approximately 10 a.m. Friday, who responded with agents and the Crime Scene Response Team. According to KBI spokesperson Natalie ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...